Cargando…
Extracorporeal life support for immune reconstitution inflammatory syndrome in HIV patients with Pneumocystis jirovecii pneumonia
Patients with immunosuppression from human immunodeficiency virus (HIV) have been traditionally considered poor candidates for extracorporeal membrane oxygenation (ECMO) because of high in-hospital mortality and poor long-term survival. Highly active antiretroviral therapy (HAART) has improved survi...
Autores principales: | Ramanathan, Kollengode, Svasti, Julian K., MacLaren, Graeme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101969/ https://www.ncbi.nlm.nih.gov/pubmed/29574652 http://dx.doi.org/10.1007/s10047-018-1036-3 |
Ejemplares similares
-
Disseminated adenoviral disease in immunocompetent adults supported with extracorporeal membrane oxygenation
por: Murughan, Kavita, et al.
Publicado: (2020) -
Extracorporeal membrane oxygenation in Pneumocystis jirovecii pneumonia: outcome in HIV and non-HIV patients
por: Rilinger, Jonathan, et al.
Publicado: (2019) -
Autopsy examination after extracorporeal membrane oxygenation: ‘Mortuis vivos docent’
por: Ramanathan, Kollengode, et al.
Publicado: (2020) -
Concurrent Use of Renal Replacement Therapy during Extracorporeal Membrane Oxygenation Support: A Systematic Review and Meta-Analysis
por: Mitra, Saikat, et al.
Publicado: (2021) -
Extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome: a narrative review
por: Alessandri, Francesco, et al.
Publicado: (2023)